The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer

Introduction: Non-small cell lung cancer (NSCLC) is the second most common cancer globally. The mesenchymal-epithelial transition (MET) proto-oncogene can be targeted in NSCLC patients. Methods: We performed a literature search on PubMed in December 2019 for studies on MET inhibitors and NSCLC. Phas...

Descripción completa

Detalles Bibliográficos
Autores principales: De Mello, Ramon Andrade, Neves, Nathália Moisés, Amaral, Giovanna Araújo, Lippo, Estela Gudin, Castelo-Branco, Pedro, Pozza, Daniel Humberto, Tajima, Carla Chizuru, Antoniou, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356188/
https://www.ncbi.nlm.nih.gov/pubmed/32575417
http://dx.doi.org/10.3390/jcm9061918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356188/
https://www.ncbi.nlm.nih.gov/pubmed/32575417
http://dx.doi.org/10.3390/jcm9061918

Ejemplares similares